Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. Apiñaniz

Pcv104 - Beta-Blockers, Angiotensin Ii, and Angiotensin-Converting Enzyme Inhibitors in Patients With Heart Failure. Differences in Prescription by Gender, Socioeconomic Status and Comorbidity After a First Hospitalization for Heart Failure

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Related publications

Up-Titrating Angiotensin-Converting Enzyme Inhibitors in Heart Failure: Evidence and Challenges

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Heart Failure With Chronic Kidney Disease ― Propensity Score Matching Analysis ―

Circulation Journal
MedicineCardiovascular MedicineCardiology
2019English

Addition of Losartan to Angiotensin-Converting Enzyme Inhibitors Improves Insulin Resistance in Patients With Chronic Heart Failure Treated Without Β-Blockers

Circulation Journal
MedicineCardiovascular MedicineCardiology
2010English

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Antagonists in Rats With Heart Failure. Role of Kinins and Angiotensin II Type 2 Receptors.

Journal of Clinical Investigation
Medicine
1997English

Race and Association of Angiotensin Converting Enzyme/Angiotensin Receptor Blocker Exposure With Outcome in Heart Failure

Journal of Cardiovascular Medicine
MedicineCardiovascular MedicineCardiology
2015English

Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors

CMAJ
Medicine
2011English

Effect of Different Angiotensin-Converting-Enzyme Inhibitors on Mortality Among Elderly Patients With Congestive Heart Failure

CMAJ
Medicine
2008English

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2006English

Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin‐Converting Enzyme Inhibitor or Angiotensin‐Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy